In human prostate cancer cells, HDAC inhibition, after sulforaphane treatment, is followed by a rise of global histone acetylation and consequent binding on p21 and Bax gene promoters, leading to apoptotic processes. The gene discussed is HDAC9; the disease is prostate carcinoma.